Liraglutide improves follicle development in polycystic ovary syndrome by inhibiting CXCL10 secretion

• 主要な著者: Min Zhao (著者), Baoying Liao (著者), Chuyu Yun (著者), Xinyu Qi (著者), Yanli Pang (著者)
• フォーマット: 図書
• 出版事項: BMC, 2024-08-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Abstract Background At present, a number of clinical trials have been carried out on GLP-1 receptor agonist liraglutide in the treatment of polycystic ovary syndrome (PCOS). However, the effect of liraglutide on follicle development and its specific mechanism are still unclear. Methods RNA sequencin...